Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen.
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
All biological function is dependent on how different proteins interact with each other. Protein-protein interactions ...
BACKGROUND: Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells.
Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...
Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...
Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...
Drs Ursula A. Matulonis and Panagiotis A. Konstantinopoulos discuss hormonal therapy updates and different ways to target and ...
A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...
Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...
1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan. 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Harbin Medical ...
Ib Studies usually conducted in patients diagnosed with the disease, or condition for which the study drug is intended; can demonstrate ''proof of concept'' Phase II Controlled clinical studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results